CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study
about
A genome-wide association study identifies protein quantitative trait loci (pQTLs)Genome-wide association with select biomarker traits in the Framingham Heart StudyAn oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesionGenetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorderRegulation of atherogenesis by chemokines and chemokine receptorsGenetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritisThe relation of genetic and environmental factors to systemic inflammatory biomarker concentrationsDuffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators.Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health AdministrationInterleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study.Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients.Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection.Serum monocyte chemoattractant protein-1 concentrations associate with diabetes status but not arterial stiffness in children with type 1 diabetesChemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery diseaseCCL2 and CCR2 variants are associated with skeletal muscle strength and change in strength with resistance training.Genetic and biochemical determinants of serum concentrations of monocyte chemoattractant protein-1, a potential neural tube defect risk factor.The rs1024611 regulatory region polymorphism is associated with CCL2 allelic expression imbalance.Single nucleotide polymorphisms in MCP-1 and its receptor are associated with the risk of age related macular degeneration.Gender-specific effects of genetic variants within Th1 and Th17 cell-mediated immune response genes on the risk of developing rheumatoid arthritis.Progenitor cells in pulmonary vascular remodeling.Folate/homocysteine phenotypes and MTHFR 677C>T genotypes are associated with serum levels of monocyte chemoattractant protein-1.Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infectionGenetic association study of coronary collateral circulation in patients with coronary artery disease using 22 single nucleotide polymorphisms corresponding to 10 genes involved in postischemic neovascularization.Pathophysiology and Medical Treatment of Carotid Artery Stenosis.The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients.Touch of chemokines.Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis.MCP-1 -2518 A/G single nucleotide polymorphism in Slovak patients with systemic sclerosis.Combinations of Polymorphic Markers of Chemokine Genes, Their Receptors and Acute Phase Protein Genes As Potential Predictors of Coronary Heart Diseases.Molecular genetics of myocardial infarctionA new era in finding Type 2 diabetes genes-the unusual suspects.The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility.Integrating soluble biomarkers and imaging technologies in the identification of vulnerable atherosclerotic patients.Association of inflammatory gene polymorphisms and conventional risk factors with arterial stiffness by age.Associations Between Macrophage Colony-Stimulating Factor and Monocyte Chemotactic Protein 1 in Plasma and First-Time Coronary Events: A Nested Case-Control StudyInflammatory biomarkers are associated with total brain volume: the Framingham Heart Study.Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes.Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.
P2860
Q21145048-8018EFC5-EE97-4A29-A670-0DAD48F0FA6AQ21261433-14879B4B-A21E-49EB-A3E5-75395F649EE4Q24300694-9496588A-D363-4227-A6D8-7F34282F790FQ26865707-F884A34F-53B9-49A3-AAA9-18C986F8C2F7Q27003124-FF5C9938-5B87-4BD7-B84F-65EB189E6BB7Q28262855-41AF40FA-8B10-4216-ABE0-13323547D3E8Q30495275-B3541E5F-0220-48CE-9C72-CC465B75CE2DQ30495417-16D97CDC-1EC5-4FBF-AFA6-2D7F5BD2AAB9Q30885473-D1DF8D61-A4A0-4C43-80A2-36AB0F0804F9Q31143614-4D38DB06-CC83-42D1-9EE5-C0BBD9E3C9DDQ34038256-47BF912F-0C0A-4FED-9B62-8E9F753F4C2BQ34166023-105DAD6F-8134-4419-8F1A-43C5B88E8D44Q34182454-144E49A1-19ED-475C-9867-781A9606475CQ34249914-EF82A99E-82D3-4226-B877-4F13413D0F7BQ34411332-EC6868FB-B074-4792-A6F7-6268131B3114Q34426826-88970E52-1E66-40FB-B414-202DB4615DE1Q34457521-00C7611E-9D72-44E7-AF5A-EE77653F9B87Q34482415-3793C824-4FE8-424B-A456-D9C3EF77AD79Q34490687-38A86D0F-AB9B-471C-9A1C-F09A5962E942Q34983577-5898383E-E014-46D1-B4FB-D3829300159BQ35412268-8E608A91-9EB1-4172-91FF-B71E0A2D7DD3Q35471664-A4E0CBCC-1136-463D-BD90-F4AB5EC27D04Q35473503-1C68E3C6-14B2-4161-8838-C1EB13862CCDQ35626327-A50D75C0-F3E1-4F10-BB47-B6E45724C72FQ36065338-BD1FA18D-46FE-4371-9C9A-CD3B258A0E6DQ36069567-E9ACBAE4-310C-4478-BA29-C91FADF4B481Q36090029-5A273FAE-31F4-4C53-A6F9-32009AC98FBBQ36660105-3BBF83A7-4253-4124-87D5-E2A8836593EDQ36692526-D2BC2A1C-40F0-49BB-A0C6-8951E5D5684EQ36815424-F92EDE5E-595C-48DA-B1FE-435CD224857FQ36843011-F2DCC0BF-B540-4FD6-B2C8-9253D658F0B4Q36846732-298B8DCD-5CF4-47E7-BEF8-9D737315DBD6Q36937324-7D242019-C999-43EF-8E32-E434A3249A0DQ37277958-DFCAA4B0-00DC-4099-866A-4B5CECEB3F2BQ37326035-D89160BB-5082-4AA6-8879-C0EB6876A963Q37364359-DFC7DEA9-EC64-4213-839C-889A4506725FQ37379665-8EBBC3E7-52EA-43BD-AE74-590742ED9B4BQ37396582-BB19014E-5EE5-4639-97D2-4A9BC154A678Q37400830-018E82CF-08F7-4A57-BE95-525206605911Q37432097-35C48616-C561-4945-8D9E-48BDFDC499C2
P2860
CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
CCL2 polymorphisms are associa ...... in the Framingham Heart Study
@ast
CCL2 polymorphisms are associa ...... in the Framingham Heart Study
@en
CCL2 polymorphisms are associa ...... in the Framingham Heart Study
@nl
type
label
CCL2 polymorphisms are associa ...... in the Framingham Heart Study
@ast
CCL2 polymorphisms are associa ...... in the Framingham Heart Study
@en
CCL2 polymorphisms are associa ...... in the Framingham Heart Study
@nl
prefLabel
CCL2 polymorphisms are associa ...... in the Framingham Heart Study
@ast
CCL2 polymorphisms are associa ...... in the Framingham Heart Study
@en
CCL2 polymorphisms are associa ...... in the Framingham Heart Study
@nl
P2093
P50
P3181
P1433
P1476
CCL2 polymorphisms are associa ...... in the Framingham Heart Study
@en
P2093
Christopher J O'Donnell
Joel N Hirschhorn
John F Keaney
L Adrienne Cupples
Qiong Yang
P304
P3181
P356
10.1161/CIRCULATIONAHA.105.543579
P407
P50
P577
2005-08-23T00:00:00Z